Moreover, because the NRG-ErbB4 signaling pathway functionally interacts to regulate synaptic and network properties underlying complex behavioral traits, our findings highlight why classical therapeutic approaches targeting specific neurotransmitter pathways to treat the diverse symptoms in psychiatric disorders, including schizophrenia, have had relatively little success. Here, ERBB4 is linked to psychiatric disorder.